Skip to main content
May 31, 2006

Governance: breaking the board apart

US companies are separating their top responsibilities at a faster rate than ever before, with shareholder activists often fueling changes

In March, shareholder activists once again filed a proxy proposal asking Pfizer to split the roles of CEO and chairman of the board. Charles Raeburn, Pfizer’s senior corporate counsel, says a similar proposal garnered 41 percent of the shareholder vote last year, and this spring ‘it’s conceivable that it will attract an even higher vote.’ The notion of having a chairman who does not also fill the role of chief executive is steadily gaining traction in the US. High-profile

To continue reading you need an active subscription

Subscribe
  • Quarterly issues of IR Magazine
  • Unlimited Articles online
  • Newsletter
  • Investor Perception Studies – Europe, US, Canada and Asia
  • Strategy guides
  • Whitepapers
  • Benchmarking reports
From $995*